<--- Back to Details
First PageDocument Content
American brands / CNX Nifty / S&P/TSX Composite Index / Allergan /  Plc / Actavis / Teva Pharmaceutical Industries / Valeant Pharmaceuticals / Sun Pharmaceutical / Pfizer / Mylan / Perrigo / AstraZeneca
Date: 2016-03-16 06:35:36
American brands
CNX Nifty
S&P/TSX Composite Index
Allergan
Plc
Actavis
Teva Pharmaceutical Industries
Valeant Pharmaceuticals
Sun Pharmaceutical
Pfizer
Mylan
Perrigo
AstraZeneca

imap AN IMAP INDUSTRY REPORT GLOBAL M&A REPORT

Add to Reading List

Source URL: www.kurmannpartners.com

Download Document from Source Website

File Size: 3,80 MB

Share Document on Facebook

Similar Documents

Business / Biotechnology / Economy / Pharmacy / Pharmaceutical industry / Pharmaceuticals policy / Biopharmaceutical / Pharmaceutical industry in India / Novartis / Biosimilar / Boehringer Ingelheim / Teva Pharmaceutical Industries

January 8, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Baxalta, Symphogen Ink $1.6 Billion Immuno­Oncology Deal In yet

DocID: 1rlhw - View Document

Business / Economy / Pharmaceutical sciences / Pharmaceuticals policy / Pharmacy / Pharmaceutical industry / CAC 40 / Sanofi / Novartis / Hikma Pharmaceuticals / Teva Pharmaceutical Industries / Adalimumab

December 4, 2015 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum 1. Teva, Takeda Form Generics Joint Venture in Japan Teva Pharmaceu

DocID: 1qVa0 - View Document

Chemistry / Business / Organic chemistry / Combination drugs / Ethers / Amines / Erlotinib / Pfizer / Quinazolines / Teva Pharmaceutical Industries / Atovaquone/proguanil / Novartis

Marketing authorisations which are recommended for suspension and marketing authorisation applications which do not satisfy the criteria for authorisation as adopted by the CHMP on 21 July 2016

DocID: 1qPF6 - View Document

Economy / Business / Science and technology in Israel / RTT / Chemistry / Teva Pharmaceutical Industries / Indemnity / Salbutamol

LEGAL NOTICE and TERMS OF USE Teva Respiratory, LLC (“Teva Respiratory”) maintains the sites www.ProAirHFA.com and www.MyProAir.com, and www.ProAir.com (the "sites") for your personal information, education, and comm

DocID: 1qLFt - View Document

Business / Economy / Pharmaceuticals policy / Health / Science and technology in Israel / Teva Pharmaceutical Industries / Allergan /  Plc / Generic drug / Mergers and acquisitions / Pharmaceutical industry in China / Drug Price Competition and Patent Term Restoration Act / Food and Drug Administration

Statement of the Federal Trade Commission In the Matter of Teva Pharmaceuticals Industries Ltd. and Allergan plc

DocID: 1q2DC - View Document